GLP-1 R 10mg

GLP-1 R (10mg) is an experimental, once-weekly injectable drug (a “triple agonist”) currently in Phase 3 clinical trials for treating obesity and Type 2 diabetes. GLP-1 is a component of Retatrutide. It works by targeting three hormone receptors—GLP-1, GIP, and glucagon—to reduce appetite and increase calorie expenditure significantly. Trials have shown up to a 24% reduction in body weight.